{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:40:55Z","timestamp":1770921655794,"version":"3.50.1"},"reference-count":23,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical Toxicology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1080\/15563650.2017.1347263","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T04:39:52Z","timestamp":1500007192000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of dose and outcomes for pediatric vilazodone ingestions"],"prefix":"10.1080","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2847-6372","authenticated-orcid":false,"given":"Christopher E.","family":"Gaw","sequence":"first","affiliation":[{"name":",","place":["USA"]},{"name":"Division of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0121-7055","authenticated-orcid":false,"given":"Henry A.","family":"Spiller","sequence":"additional","affiliation":[{"name":"Central Ohio Poison Center, Columbus, OH, USA;"},{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason L.","family":"Russell","sequence":"additional","affiliation":[{"name":"Central Ohio Poison Center, Columbus, OH, USA;"},{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiphalak","family":"Chounthirath","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary A.","family":"Smith","sequence":"additional","affiliation":[{"name":",","place":["USA"]},{"name":",","place":["USA"]},{"name":"Child Injury Prevention Alliance, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"U.S. Food and Drug Administration. FDA approves Viibryd to treat major depressive disorder. FDA News Release [Internet]. 2011 Jan 21; Available from: https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm240642.htm."},{"key":"e_1_3_2_3_1","unstructured":"Allergan Pharmaceuticals International Limited. Viibryd (R) [Package Insert]. Irvine CA; 2017."},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00999-5"},{"key":"e_1_3_2_5_1","unstructured":"U.S. Food and Drug Administration. Clinical Pharmacology and Biopharmaceutics Review [Internet]. 2010. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_%0Adocs\/nda\/2011\/022567Orig1s000ClinPharmR.pdf"},{"key":"e_1_3_2_6_1","first-page":"263","article-title":"Vilazodone (Viibryd) for the treatment of depression","volume":"88","author":"Gazewood J","year":"2013","unstructured":"Gazewood J, Slayton P, DeGeorge K. Vilazodone (Viibryd) for the treatment of depression. Am Fam Physician. 2013;88:263\u2013264.","journal-title":"Am Fam Physician"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0490-y"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m09885"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S20683"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701285289"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2012.678497"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2012.06.020"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2015.04.032"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2017.1287375"},{"key":"e_1_3_2_15_1","unstructured":"American Association of Poison Control Centers. National Poison Data System (NPDS): NPDS Coding Users\u2019 Manual Version 3.1. 2014."},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2011.08.004"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-010-0027-4"},{"key":"e_1_3_2_18_1","first-page":"1139","article-title":"Prevention, recognition, and management of serotonin syndrome","volume":"81","author":"Ables AZ","year":"2010","unstructured":"Ables AZ, Nagubilli R. Prevention, recognition, and management of serotonin syndrome. Am Fam Physician. 2010;81:1139\u20131142.","journal-title":"Am Fam Physician"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(99)70313-6"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650801938654"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2005.07.012"},{"key":"e_1_3_2_23_1","first-page":"997","article-title":"Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence. Pharmacoepidemiol","volume":"21","author":"Czaja AS","year":"2012","unstructured":"Czaja AS, Valuck R. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence. Pharmacoepidemiol Drug Saf. 2012;21:997\u20131004.","journal-title":"Drug Saf"},{"key":"e_1_3_2_24_1","unstructured":"Centers for Medicare and Medicaid Services. Antidepressant medications: use in pediatric patients [Internet]. 2015; [cited 2017 Apr]. Available from: https:\/\/www.cms.gov\/Medicare-Medicaid-Coordination\/Fraud-Prevention\/Medicaid-Integrity-Education\/Pharmacy-Education-Materials\/Downloads\/ad-pediatric-factsheet11-14.pdf"}],"container-title":["Clinical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15563650.2017.1347263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:59:24Z","timestamp":1770919164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15563650.2017.1347263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1080\/15563650.2017.1347263"],"URL":"https:\/\/doi.org\/10.1080\/15563650.2017.1347263","relation":{},"ISSN":["1556-3650","1556-9519"],"issn-type":[{"value":"1556-3650","type":"print"},{"value":"1556-9519","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}